Table 3.
Hazard Ratios for Patients With OPC Known to be HPV Positive and With Imputed HPV-Positive Status by RPA Stage Adjusted for Age, Pack-Years, and Chemotherapy Use
RPA stage | No. (%) of Patients | Analysis by Type of HPV-Positive Status | |||
---|---|---|---|---|---|
Known | Imputed | ||||
Crude HR (95% CI) | Adjusted* HR (95% CI) | Crude HR (95% CI) | Adjusted* HR (95% CI) | ||
IA | 195 (29.5) | 1.0 (referent) | 1.0 (referent) | 1.0 (referent) | 1.0 (referent) |
IB | 219 (33.1) | 2.5 (1.1 to 5.6) | 2.1 (.9 to 4.8) | 1.4 (.9 to 2.3) | 1.4 (.8 to 2.2) |
II | 171 (25.9) | 4.4 (2.0 to 9.8) | 3.4 (1.5 to 7.8) | 2.8 (1.8 to 4.3) | 2.6 (1.6 to 4.3) |
III | 76 (11.5) | 8.2 (3.7 to 18.5) | 5.0 (2.0 to 12.2) | 6.4 (4.1 to 9.9) | 5.2 (3.0 to 8.9) |
Abbreviations: HPV, human papillomavirus; HR, hazard ratio; OPC, oropharyngeal cancer; RPA, recursive partitioning analysis.
Adjusted for age, smoking pack-years, and chemotherapy use.